These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Yeomans ND; Graham DY; Husni ME; Solomon DH; Stevens T; Vargo J; Wang Q; Wisniewski LM; Wolski KE; Borer JS; Libby P; Lincoff AM; Lüscher TF; Bao W; Walker C; Nissen SE; Aliment Pharmacol Ther; 2018 Jun; 47(11):1453-1463. PubMed ID: 29667211 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Farkouh ME; Greenberg JD; Jeger RV; Ramanathan K; Verheugt FW; Chesebro JH; Kirshner H; Hochman JS; Lay CL; Ruland S; Mellein B; Matchaba PT; Fuster V; Abramson SB Ann Rheum Dis; 2007 Jun; 66(6):764-70. PubMed ID: 17412741 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cardiovascular risk associated with SKI306X use in patients with osteoarthritis and rheumatoid arthritis. Woo Y; Hyun MK J Ethnopharmacol; 2017 Jul; 207():42-46. PubMed ID: 28602866 [TBL] [Abstract][Full Text] [Related]
11. [Granulated ibuprofen in rheumatoid arthritis. Comparison of its efficacy and tolerability with naproxen]. Frizziero L; Zizzi F Clin Ter; 1986 Jun; 117(6):493-7. PubMed ID: 3742970 [No Abstract] [Full Text] [Related]
12. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis. Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577 [TBL] [Abstract][Full Text] [Related]
13. Celecoxib in osteoarthritis and rheumatoid arthritis: new preparation. As disappointing as rofecoxib. Prescrire Int; 2001 Apr; 10(52):46-9. PubMed ID: 11718158 [TBL] [Abstract][Full Text] [Related]
14. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Farkouh ME; Kirshner H; Harrington RA; Ruland S; Verheugt FW; Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Gimona A; Matchaba P; Hawkey CJ; Chesebro JH; Lancet; 2004 Aug 21-27; 364(9435):675-84. PubMed ID: 15325832 [TBL] [Abstract][Full Text] [Related]
15. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Matchaba P; Gimona A; Hawkey CJ; Lancet; 2004 Aug 21-27; 364(9435):665-74. PubMed ID: 15325831 [TBL] [Abstract][Full Text] [Related]
16. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Becker MC; Wang TH; Wisniewski L; Wolski K; Libby P; Lüscher TF; Borer JS; Mascette AM; Husni ME; Solomon DH; Graham DY; Yeomans ND; Krum H; Ruschitzka F; Lincoff AM; Nissen SE; Am Heart J; 2009 Apr; 157(4):606-12. PubMed ID: 19332185 [TBL] [Abstract][Full Text] [Related]
17. Diclofenac sodium in the treatment of rheumatoid arthritis and osteoarthritis. Caldwell JR Semin Arthritis Rheum; 1985 Nov; 15(2 Suppl 1):73-9. PubMed ID: 4081794 [No Abstract] [Full Text] [Related]
18. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Goodwin JS; Regan M Arthritis Rheum; 1982 Aug; 25(8):1013-5. PubMed ID: 7115443 [No Abstract] [Full Text] [Related]
19. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327 [TBL] [Abstract][Full Text] [Related]
20. Rofecoxib in rheumatoid arthritis: new indication. No better that other NSAIDS. Prescrire Int; 2003 Jun; 12(65):89-90. PubMed ID: 12825570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]